Literature DB >> 29599118

Risk assessment in pulmonary arterial hypertension.

Athénaïs Boucly1,2,3, Jason Weatherald4, Marc Humbert1,2,3, Olivier Sitbon5,2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29599118     DOI： 10.1183/13993003.00279-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

Review 1.  Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.

Authors:  Shu-Hao Wu; Yih-Jer Wu
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

Review 2.  The 6th World Symposium on Pulmonary Hypertension: what's old is new.

Authors:  David F Condon; Nils P Nickel; Ryan Anderson; Shireen Mirza; Vinicio A de Jesus Perez
Journal:  F1000Res       Date:  2019-06-19

3.  Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.

Authors:  Panagiota Xanthouli; Maria Koegler; Alberto M Marra; Nicola Benjamin; Lukas Fischer; Christina A Eichstaedt; Satenik Harutyunova; Christian Nagel; Ekkehard Grünig; Benjamin Egenlauf
Journal:  Respir Res       Date:  2020-05-24

4.  Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.

Authors:  Marc Humbert; Edmund M T Lau
Journal:  Am J Respir Crit Care Med       Date:  2021-03-15       Impact factor: 21.405

5.  Electrical impedance tomography in pulmonary arterial hypertension.

Authors:  André L D Hovnanian; Eduardo L V Costa; Susana Hoette; Caio J C S Fernandes; Carlos V P Jardim; Bruno A Dias; Luciana T K Morinaga; Marcelo B P Amato; Rogério Souza
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

6.  Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography.

Authors:  Valentina Mercurio; Hussein J Hassan; Mario Naranjo; Alessandra Cuomo; Jeremy A Mazurek; Paul R Forfia; Aparna Balasubramanian; Catherine E Simpson; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Steven Hsu; Monica Mukherjee; Paul M Hassoun
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

7.  External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Pascal de Groote; Vincent Cottin; Grégoire Prévot; Ari Chaouat; François Picard; Delphine Horeau-Langlard; Arnaud Bourdin; Etienne-Marie Jutant; Antoine Beurnier; Mitja Jevnikar; Xavier Jaïs; Gérald Simonneau; David Montani; Olivier Sitbon; Marc Humbert
Journal:  Eur Respir J       Date:  2022-06-30       Impact factor: 33.795

8.  Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Vasiliki Kalliopi Bournia; Iraklis Tsangaris; Loukianos Rallidis; Dimitrios Konstantonis; Frantzeska Frantzeskaki; Anastasia Anthi; Stylianos E Orfanos; Eftychia Demerouti; Panagiotis Karyofillis; Vassilis Voudris; Katerina Laskari; Stylianos Panopoulos; Panayiotis G Vlachoyiannopoulos; Petros P Sfikakis
Journal:  Diagnostics (Basel)       Date:  2020-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.